摘要
目的:探讨缬沙坦对原发性高血压(EH)患者微量蛋白尿(Malb)的影响。方法:45例原发性高血压伴Malb患者口服缬沙坦80～160mg/d,治疗8周,治疗前后观察血压变化及Malb水平。结果:治疗后血压及Malb水平较治疗前明显下降,差异有显著性(P<0.05);未见明显不良反应。结论:缬沙坦可能具有肾脏保护作用。
Objective：To study the effect of valsartan on micro albuminuria （Malb） in the patients with essential hypertension. Methods： Valsartan 80-160 mg/d was administered for 45 cases of the essential hypertension patients with Malb, the levels of blood pressure and Malb were observed before and after 8 weeks treatment. Results：The levels of blood pressure and Malb in post-treatment were significantly lower than those in prior treatment （P〈0.05）; and there was no significant adverse reactions. Conclusion：Valsartan maybe have a protection for kidney.
出处
《中国医药导报》
CAS
2008年第24期87-88,共2页
China Medical Herald
